The estimated Net Worth of Amir Elstein is at least $38 million dollars as of 15 June 2024. Mr. Elstein owns over 21,108 units of Teva- Pharmaceutical Industries stock worth over $37,614,185 and over the last 6 years he sold TEVA stock worth over $0. In addition, he makes $340,508 as Independent Director at Teva- Pharmaceutical Industries.
Sign up
Mr. Elstein TEVA stock SEC Form 4 insiders trading
Amir has made over 7 trades of the Teva- Pharmaceutical Industries stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 21,108 units of TEVA stock worth $379,100 on 15 June 2024.
The largest trade he's ever made was exercising 21,108 units of Teva- Pharmaceutical Industries stock on 15 June 2024 worth over $379,100. On average, Amir trades about 5,980 units every 92 days since 2018. As of 15 June 2024 he still owns at least 2,094,331 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Mr. Elstein stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Amir Elstein biography
Amir Elstein serves as Independent Director of the Company. Mr. Elstein serves as Chairman of the Board of Tower Semiconductor Ltd. and Chairman of the Israel Democracy Institute. Mr. Elstein also serves as Chairman or as a member of the board of directors of several academic, scientific, educational, social and cultural institutions. Mr. Elstein served as Chairman of the Board of Governors of the Jerusalem College of Engineering from 2009 to 2018 and as Chairman of the Board of Directors of Israel Corporation from 2010 to 2013. From 2004 to 2008, Mr. Elstein was a member of Teva’s senior management, most recently as Executive Vice President, Global Pharmaceutical Resources. From 1995 to 2004, Mr. Elstein served on Teva’s Board of Directors. Prior to joining Teva as an executive in 2004, Mr. Elstein held a number of executive positions at Intel Corporation, most recently as General Manager of Intel Electronics Ltd., an Israeli subsidiary of Intel Corporation.
What is the salary of Amir Elstein?
As the Independent Director of Teva- Pharmaceutical Industries, the total compensation of Amir Elstein at Teva- Pharmaceutical Industries is $340,508. There are 13 executives at Teva- Pharmaceutical Industries getting paid more, with Kaare Schultz having the highest compensation of $11,596,600.
How old is Amir Elstein?
Amir Elstein is 64, he's been the Independent Director of Teva- Pharmaceutical Industries since 2014. There are 3 older and 25 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.
What's Amir Elstein's mailing address?
Amir's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.
Insiders trading at Teva- Pharmaceutical Industries
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over $31,332,399 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 . The most active insiders traders include Sol J Barer, Tal Zvi Zaks et Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of $636,538. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth $231,181.
What does Teva- Pharmaceutical Industries do?
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
What does Teva- Pharmaceutical Industries's logo look like?
Complete history of Mr. Elstein stock trades at Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries executives and stock owners
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include:
-
Kaare Schultz,
President, Chief Executive Officer, Director -
Kare Schultz,
Pres, CEO & Director -
Mark Sabag,
Executive Vice President, Chief Human Resources Officer and Global Communications and Brand -
Hafrun Fridriksdottir,
Executive Vice President - Global R&D -
Brendan O'Grady,
Executive Vice President - North America Commercial -
Gianfranco Nazzi,
Executive Vice President - International Markets Commercial -
Dr. Hafrun Fridriksdottir,
Exec. VP of Global R&D -
Gianfranco Nazzi,
Exec. VP of International Markets Commercial -
Eric Drape,
Exec. VP of Global Operations -
Eliyahu Sharon Kalif,
Exec. VP & CFO -
Sol Barer,
Independent Chairman of the Board -
Nechemia Peres,
Independent Director -
Gerald Lieberman,
Independent Director -
Amir Elstein,
Independent Director -
Roberto Mignone,
Independent Director -
Rosemary Crane,
Independent Director -
Jean-Michel Halfon,
Independent Director -
Perry Nisen,
Independent Director -
Ronit Satchi-Fainaro,
Independent Director -
Eliyahu Kalif,
Chief Financial Officer, Executive Vice President -
Kevin Mannix,
Senior Vice President, Investor Relations -
Janet Vergis,
Independent Director -
Abbas Hussain,
Independent Director -
David Stark,
Executive Vice President, Chief Legal Officer -
Eric Drape,
Executive Vice President - Global Operations -
Sven Dethlefs,
Executive Vice President - Global Marketing & Portfolio -
Richard Daniell,
Executive Vice President - European Commercial -
Eli Shani,
Exec. VP of Global Marketing & Portfolio -
Galia Inbar,
Exec. VP, Chief HR Officer and Head of Global Communications, Brand & ESG -
David M. Stark,
Exec. VP & Chief Legal Officer -
Amir Weiss,
Sr. VP & Chief Accounting Officer -
Lori Queisser,
Sr. VP & Global Compliance Officer -
Andrew J. Weil CPA,
Chief Accounting Officer -
Eric Drapé,
Exec. VP of Global Operations -
Iris Beck Codner,
EVP Global Brand&Communication -
Kare Schultz,
President and CEO -
Michael James Mc Clellan,
EVP, Chief Financial Officer -
Notaristefani Carlo De,
Executive VP Global Operations -
Placid Jover,
See "Remarks" -
Deborah A Griffin,
Chief Accounting Officer -
Varda Shalev,
-
Dan S Suesskind,
Director -
Murray A Goldberg,
Director -
Dov Bergwerk,
Acting Chief Legal Officer -
David R. Mc Avoy,
EVP, Chief Legal Officer -
Andrew Weil,
Chief Accounting Officer -
Galia Inbar,
See "Remarks" -
Eli Shani,
EVP,Global Marketing&Portfolio -
Angus Grant,
EVP, Business Development -
Eric A Hughes,
See "Remarks" -
Vikki L Conway,
See "Remarks" -
Christine Fox,
EVP, Head of U.S. Commercial -
Amir Weiss,
Chief Accounting Officer -
Richard D Francis,
President and CEO -
Matthew Shields,
EVP, Global Operations -
Tal Zvi Zaks,